Transplante autólogo de células-tronco hematopoiéticas sem uso de hemocomponentes.

In this review, we present 1) scientific basis for the use of high dose immunosuppression followed by autologous peripheral blood hematopoietic stem cell transplantation for

Autologous stem cell transplantation in elderly patients (> or = 60 years) with diffuse large B-cell lymphoma: an analysis based on data in the European Blood and

This is the irst case reported of pancreatoblastoma that was treated with autologous hematopoietic stem cell transplantation as irst line treatment without radiotherapy at the site

Clostridium difficile infection after adult autologous stem cell transplantation: a multicenter study of epidemiology and risk factors. Biol Blood

Hematopoietic stem cell transplantation in children with acute leukemia: similar outcomes in recipients of umbilical cord blood versus marrow or peripheral blood stem cells from

The immature platelet fraction is a useful marker for predicting the timing of platelet recovery in patients with cancer after chemotherapy and hematopoietic stem cell

Poor mobilization of peripheral blood stem cells is a risk factor for worse outcome in lymphoma patients undergoing autologous stem

The high frequency of blood transfusions among patients positive for the serological markers is in agreement with other studies (13, 15) , which showed that blood